Capitalizing on Asia as a source of growth and innovation for pharmas to narrow the gap in their pipelines, by Mr Enders Ekblom

Presenting on the above topic is Mr Anders Ekblom, Executive Vice President, Global Medicines Development, Astrazeneca, Sweden. He will be speaking at Pharma Partnering & Investment World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012. Mr Ekblom is responsible for R&D operating across drug development and life cycle management delivering submissions and …

Customizing your global regulatory strategy for efficient drug development, by Dr Joseph Scheeren, #Bayer Healthcare

Speaking on the above topic is Dr Joseph Scheeren, SVP & Head, Global Regulatory Affairs, Bayer Healthcare, United States. He will be making a presentation at Pre-clinical World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012. Dr Scheeren was born and raised in the Netherlands and studied pharmacy at the University of …